This article provides a comprehensive exploration of RNA sequencing for profiling non-coding RNAs (ncRNAs) in hepatocellular carcinoma (HCC) tissues.
This article addresses the critical challenge of false positives in the detection of long non-coding RNA (lncRNA) biomarkers for Hepatocellular Carcinoma (HCC), a major obstacle to their clinical adoption.
Long non-coding RNAs (lncRNAs) are critical regulators in hepatocellular carcinoma (HCC) pathogenesis, yet their functional characterization remains challenging.
Liquid biopsy analysis of circulating long non-coding RNAs (lncRNAs) represents a transformative approach for the non-invasive management of hepatocellular carcinoma (HCC).
This comprehensive review explores the critical role of single-cell RNA sequencing (scRNA-seq) in unraveling non-coding RNA (ncRNA) heterogeneity in Hepatocellular Carcinoma (HCC).
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, largely due to late-stage diagnosis.
This article provides a comprehensive methodological framework for researchers and drug development professionals aiming to precisely localize long non-coding RNAs (lncRNAs) in hepatocellular carcinoma (HCC) tissues using in situ hybridization...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, largely due to late-stage diagnosis.
Hepatocellular carcinoma (HCC) remains a global health challenge with high mortality, driving urgent need for novel diagnostic biomarkers and therapeutic strategies.
Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality globally, largely due to limitations in early detection.